ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 395,18
-0,48%
Dow Jones
42 051,86
0,27%
DAX
20 099,98
-0,60%
Brent Oil
80,085
-0,66%
Bitcoin
91 399,08
-3,27%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Olema Pharmaceuticals Inc (OLMA) Cours

Olema Pharmaceuticals Inc

Olema Pharmaceuticals Inc (OLMA)

NASDAQ
4,765
-0,275
( -5,46% )
Mis à jour : 15:34:51
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
4,765
Prix Achat
4,74
Prix Vente
4,79
Volume échangé
41 456
4,76 Fourchette du Jour 5,05
4,76 Plage de 52 semaines 16,775
Cap du marché
273,024M
Clôture Veille
5,04
Ouverture
4,90
Dernière Transaction
32
@
4.765
Dernière heure de transaction
15:34:46
Volume financier
US$ 202 371
VWAP
4,8816
Volume moyen (3 m)
896 451
Actions en circulation
57 297 845
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,99
Bénéfice par action (BPA)
-1,69
Chiffre d'affairess
-
Bénéfice net
-96,66M

À propos de Olema Pharmaceuticals Inc

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has c... Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
olema.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Olema Pharmaceuticals Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker OLMA. Le dernier cours de clôture d'Olema Pharmaceuticals était de US$5,04. Au cours de la dernière année, les actions de Olema Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 4,76 à US$ 16,775.

Olema Pharmaceuticals compte actuellement 57 297 845 actions en circulation. La capitalisation boursière d'Olema Pharmaceuticals est de US$288,78 million. Olema Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -2.99.

OLMA Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

il y a 3 heures
Edgar (US Regulatory)

Form 8-K - Current report

10 Janvier 2025
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

06 Janvier 2025
Edgar (US Regulatory)

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...

03 Janvier 2025
GlobeNewswire Inc.

Olema Oncology to Present at 43rd Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery...

02 Janvier 2025
GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

19 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

13 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

12 Décembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-1.175-19.78114478115.945.99834.7617000755.40899445CS
4-2.065-30.23426061496.836.874.7613158145.78968565CS
12-7.615-61.510500807812.3813.514.768964517.81741217CS
26-7.515-61.197068403912.2816.624.7671611210.08199964CS
52-6.585-58.017621145411.3516.7754.7678986711.09027345CS
156-2.215-31.73352435536.9817.791125112229.48477CS
260-42.235-89.86170212774760.27246732212.32367006CS

OLMA - Frequently Asked Questions (FAQ)

What is the current Olema Pharmaceuticals share price?
The current share price of Olema Pharmaceuticals is US$ 4,765
How many Olema Pharmaceuticals shares are in issue?
Olema Pharmaceuticals has 57 297 845 shares in issue
What is the market cap of Olema Pharmaceuticals?
The market capitalisation of Olema Pharmaceuticals is USD 288,78M
What is the 1 year trading range for Olema Pharmaceuticals share price?
Olema Pharmaceuticals has traded in the range of US$ 4,76 to US$ 16,775 during the past year
What is the PE ratio of Olema Pharmaceuticals?
The price to earnings ratio of Olema Pharmaceuticals is -2,99
What is the reporting currency for Olema Pharmaceuticals?
Olema Pharmaceuticals reports financial results in USD
What is the latest annual profit for Olema Pharmaceuticals?
The latest annual profit of Olema Pharmaceuticals is USD -96,66M
What is the registered address of Olema Pharmaceuticals?
The registered address for Olema Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Olema Pharmaceuticals website address?
The website address for Olema Pharmaceuticals is olema.com
Which industry sector does Olema Pharmaceuticals operate in?
Olema Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AALAmerican Airlines Group Inc
US$ 18,38
(0,00%)
280,83k
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70,91
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,595
(0,00%)
4,61k
AACGATA Creativity Global
US$ 0,9462
(0,00%)
26
AALAmerican Airlines Group Inc
US$ 18,38
(0,00%)
280,83k
AAGRAfrican Agriculture Holdings Inc
US$ 0,1326
(0,00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 70,91
(0,00%)
0
AADIAadi Bioscience Inc
US$ 3,595
(0,00%)
4,61k
AACGATA Creativity Global
US$ 0,9462
(0,00%)
26
GCTKGlucoTrack Inc
US$ 0,117
(0,00%)
263,41M
SVMHSRIVARU Holding Ltd
US$ 0,0618
(0,00%)
47,67M
RIMEAlgorhythm Holdings Inc
US$ 0,1348
(0,00%)
41,72M
PHIOPhio Pharmaceuticals Corporation
US$ 1,69
(0,00%)
40,38M
ATPCAgape ATP Corporation
US$ 1,26
(0,00%)
37,38M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
OLMA
Olema Pharmaceuticals
BIT
S29582
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés